I had a very negative experience with this platform and suffered a significant financial loss. Fortunately, STAUNCHVIEW . ORG was able to assist in recovering £699.00 without delays or complications. Their service was professional, efficient, and well-managed, and I would recommend them based on my experience.
What does PROFILE say about treatment for newly diagnosed crohns patients who have only received their diagnosis from the histology of a right hemicolectomy?
The Australian data shows high levels of dose escalated inflix and vedo (around 40%). Is there any evidence to support that the top down approach would reduce this, ie patients require increased dosing because they were ineffectively treated (because of dog funding constraints) up front?
Thank you Charlie so much for an excellent summary, I totally agree with you and with the data that treating Crohn's disease early a key to the successful treatment and for the prevention of complications.
I appreciate very much your great help and summarizing and false blood in the knowledge.
Where do you see ileal resection for isolated Crohn’s disease fitting into treatment strategy. ie in that patient group, is it reasonable to observe post-operatively without aggressive top-down therapy? Tailoring need for further therapy based on surveillance colonoscopy etc
I definitely agree that the Congress is a little bit short. However, this year it was much more better. ECCO also started a new initiative about developing countries, and this is a very good idea since many countries around the world below the standards, and cannot follow the guidelines
I had a very negative experience with this platform and suffered a significant financial loss. Fortunately, STAUNCHVIEW . ORG was able to assist in recovering £699.00 without delays or complications. Their service was professional, efficient, and well-managed, and I would recommend them based on my experience.
What does PROFILE say about treatment for newly diagnosed crohns patients who have only received their diagnosis from the histology of a right hemicolectomy?
Thanks Charlie, any thoughts as to why the proportion of L1 disease has increased since 2008?
The Australian data shows high levels of dose escalated inflix and vedo (around 40%). Is there any evidence to support that the top down approach would reduce this, ie patients require increased dosing because they were ineffectively treated (because of dog funding constraints) up front?
Thanks to share so useful opinions!
Financial affordability is always the challenge to proper treatment access, which is disabling!
Thank you Charlie so much for an excellent summary, I totally agree with you and with the data that treating Crohn's disease early a key to the successful treatment and for the prevention of complications.
I appreciate very much your great help and summarizing and false blood in the knowledge.
Thanks Charlie
Where do you see ileal resection for isolated Crohn’s disease fitting into treatment strategy. ie in that patient group, is it reasonable to observe post-operatively without aggressive top-down therapy? Tailoring need for further therapy based on surveillance colonoscopy etc
Super summary Charlie ! And would like to see your comments on the future of precision medicine
Charlie it was an excellent summary. I’m looking forward for the rest of your comments.
I definitely agree that the Congress is a little bit short. However, this year it was much more better. ECCO also started a new initiative about developing countries, and this is a very good idea since many countries around the world below the standards, and cannot follow the guidelines